CTRI/2020/03/023985
Not yet recruiting
未知
An open label, single arm, prospective clinical study to evaluate the safety of CUQ1720P(curcumagalactomannoside) in healthy subjects.
Akay Flavours and Aromatics Private Limited0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Akay Flavours and Aromatics Private Limited
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subjects having weight \> 50 Kg
- •2\.Subjects who have no evidence of any underlying disease
- •3\.Women of child bearing potential practicing an acceptable method of birth control as judged by the investigator(s) \[such as condoms, foams, jellies, diaphragm, intrauterine device, oral or long acting injected contraceptives] from at least 2 months prior to study entry and through the duration of the study; or postmenopausal for at least 1 year, surgically sterile (bilateral tubal ligation, bilateral oophorectomy, or hysterectomy has been performed on the subject); with a negative urine pregnancy test.
- •4\. Must be willing and able to give informed consent and comply with the study procedures
Exclusion Criteria
- •1Subjects suffering from any chronic health conditions (e.g. diabetes, hypertension, chronic renal failure, heart, thyroid and liver disease) requiring medical treatment
- •2History of Chronic metabolic disease, Psychiatric illness,Drug abuse, smoking, abuse/addiction to alcohol,Eating disorder such as bulimia or binge eating,Endocrine abnormalities including stable thyroid disease, Cardiovascular surgery / History of any major surgery
- •3Subjects allergic to herbal products
- •4Known HIV or Hepatitis B positive or any other immuno\-compromised state
- •5Diagnosis of any other clinically significant medical condition which in opinion of investigator may jeopardize subjectâ??s safety and preclude trial participation
- •6Currently participating or having participated in another clinical trial during the last 1 month prior to the beginning of this study
- •7\.Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to evaluate the safety of Puremeric in Healthy volunteersCTRI/2019/10/021611Vidya Herbs P Ltd
Completed
Phase 2
Clinical study of Hair Oil formulation in Hair loss in females.Health Condition 1: null- Mild to moderate Hair loss in femalesCTRI/2018/05/014122Emami Ltd50
Completed
Not Applicable
Slim honey in ObesityHealth Condition 1: E00-E89- Endocrine, nutritional and metabolic diseasesCTRI/2020/08/027196Royal Bee Natural Products Pvt Ltd30
Suspended
Phase 3
Clinical Trial to evaluate the effects of Dibosudha tablet and Diabosudha Liquid Diabetes Mellitus type 2.CTRI/2022/11/047116Sahyadri Ayurvedic Life Pvt. Ltd.1
Not yet recruiting
Phase 3
A clinical study to evaluate the the Anabolic Efficacy of PRP-02 in Healthy Human Adults.CTRI/2024/06/068758Amway Global Services India (AGSI)